URGN Competitors & Alternatives
Compare UroGen Pharma Ltd with similar stocks in the same industry
Biotechnology
URGN
Main Stock$38.02
Tradestie Score
59
Market Cap
$824.20M
Revenue Growth
1.5%
Analyst Upside
-2.4%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.69
|
$1.97B | - | 63 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.64
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$107.95
|
$1.92B | - | 55 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$78.93
|
$1.90B | 466.6 | 55 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$41.20
|
$1.84B | - | 59 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.50
|
$1.81B | - | 64 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$8.11
|
$1.78B | - | 59 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$23.07
|
$1.78B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.40
|
$1.74B | - | 67 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.37
|
$1.68B | - | 57 | Compare |
More URGN Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry